TELL ME MORE ABOUT THIS STUDY
A randomised, double-blind, placebo-controlled, parallel group, multicentre, phase III study to evaluate the efficacy and safety of an investigational medicine in adult participants with moderate to very severe chronic obstructive pulmonary disease.
Enrolling Adult Participants 40-80 years old
Study Location(s): Bowling Green, KY & Owensboro, KY
What is COPD?
Chronic obstructive pulmonary disease, or COPD, refers to a group of diseases that cause airflow blockage and breathing-related problems. It includes emphysema and chronic bronchitis. COPD makes breathing difficult for the 16 million Americans who have this disease. Millions more people suffer from COPD, but have not been diagnosed and are not being treated. Although there is no cure for COPD, it can be treated. (Content source: CDC.)
There is no cost to participate. Volunteers receive no cost investigational medicine and no cost health exams. No insurance needed. Time and travel compensation is TBD.